Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-19-004233

Director bought 8,000 shares at $0.68 ($5,440)

From the SEC's structured data for this filing

Trades in this filing

Mohan Pankaj · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-01-15 Purchase : show line 1 in the form +8,000 $0.68 $5,440 7,064,553 D
Open-market purchases · 8,000 sh · avg $0.68 · $5,440
Loading xslF345X03/doc4.xml…